Deal

10x Genomics acquires Tetramer Shop ApS

January 2021 Acquisition Ready
01 Scorecard

The deal at a glance

Private-market deal
10x Genomics acquires Tetramer Shop ApS
Deal value
$8.5 million
Sector
Immunology
Date
January 2021
VectorShift
Made on VectorShift

10x Genomics acquired Tetramer Shop ApS for $8.5 million, a transaction completed in January 2021, structured as All-cash acquisition of 100% of outstanding shares; total cash consideration $8.5M net of $0.2M cash acquired, including $1.5M contingent consideration (paid 2022).

Tetramer Shop ApS operates in Immunology, is based in Copenhagen, Denmark. Acquisition of Copenhagen, Denmark-based Tetramer Shop ApS, a life sciences technology company that developed and provided reagents for precise monitoring of antigen-specific T cells in research and development. The acquisition closed January 8, 2021 and was announced publicly at 10x's inaugural Xperience event on February 24, 2021.

Strengthen 10x's immunology efforts and accelerate development of T cell receptor-based research tools; technology commercialized with the BEAM-T product.

MHC molecule expertise commercialized via the BEAM-T product to strengthen 10x's immunology portfolio. Immunology / BEAM-T product

We had a solid start to the year highlighted by strong growth across the business and the incredible response to the innovation revealed at our inaugural Xperience event.
Serge Saxonov, Co-founder and CEO of 10x Genomics
Advisors not disclosed

No advisory firms have been disclosed for this transaction.

See how VectorShift works for your firm

Request Demo